Keith Nalepka - Bioelectronics Corp VP Director

BIEL Stock

USD 0.0003 0.0001 50.00%

Insider

Keith Nalepka is VP Director of Bioelectronics Corp

Age	49
Phone	301 874 4890
Web	https://www.bielcorp.com

Bioelectronics Corp Management Efficiency

The company has return on total asset (ROA) of (0.3367) % which means that it has lost $0.3367 on every $100 spent on assets. This is way below average. Bioelectronics Corp's management efficiency ratios could be used to measure how well Bioelectronics Corp manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Bioelectronics Corp to Peers

Predict price of Bioelectronics Corp

Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity.

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange. Bioelectronics Corp [BIEL] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Asset

-0.34

Bioelectronics Corp Leadership Team

Elected by the shareholders, the Bioelectronics Corp's board of directors comprises two types of representatives: Bioelectronics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioelectronics. The board's role is to monitor Bioelectronics Corp's management team and ensure that shareholders' interests are well served. Bioelectronics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioelectronics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Kelly Whelan, President, CEO
	Keith Nalepka, VP Director
	John Martinez, Senior Engineer
	Andrew Whelan, CEO and President Founder, CFO and Director

Bioelectronics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bioelectronics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Asset	-0.34
	Profit Margin	(0.18) %
	Operating Margin	(0.09) %
	Current Valuation	52.16 M
	Shares Outstanding	24.71 B
	Price To Sales	30.73 X
	Revenue	1.61 M
	Gross Profit	795.53 K
	EBITDA	(1.36 M)
	Net Income	(289.82 K)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC